Literature DB >> 35356993

Ulcerative Tuberculosis in a Patient Treated with Adalimumab.

Outi Varpuluoma, Suvi-Päivikki Sinikumpu, Päivi Jackson, Kaisa Tasanen1, Laura Huilaja.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35356993      PMCID： PMC9558327          DOI： 10.2340/actadv.v102.1616

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  13 in total

Review 1.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 2.  Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.

Authors:  R Diel; D Goletti; G Ferrara; G Bothamley; D Cirillo; B Kampmann; C Lange; M Losi; R Markova; G B Migliori; A Nienhaus; M Ruhwald; D Wagner; J P Zellweger; E Huitric; A Sandgren; D Manissero
Journal:  Eur Respir J       Date:  2010-10-28       Impact factor: 16.671

Review 3.  Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis.

Authors:  Sunny H Wong; Qinyan Gao; Kelvin K F Tsoi; William K K Wu; Lai-shan Tam; Nelson Lee; Francis K L Chan; Justin C Y Wu; Joseph J Y Sung; Siew C Ng
Journal:  Thorax       Date:  2015-12-11       Impact factor: 9.139

Review 4.  Latent Mycobacterium tuberculosis infection.

Authors:  Haileyesus Getahun; Alberto Matteelli; Richard E Chaisson; Mario Raviglione
Journal:  N Engl J Med       Date:  2015-05-28       Impact factor: 91.245

Review 5.  Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.

Authors:  Madhukar Pai; Claudia M Denkinger; Sandra V Kik; Molebogeng X Rangaka; Alice Zwerling; Olivia Oxlade; John Z Metcalfe; Adithya Cattamanchi; David W Dowdy; Keertan Dheda; Niaz Banaei
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

6.  Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.

Authors:  Johan Askling; C Michael Fored; Lena Brandt; Eva Baecklund; Lennart Bertilsson; Lars Cöster; Pierre Geborek; Lennart T Jacobsson; Staffan Lindblad; Jörgen Lysholm; Solbritt Rantapää-Dahlqvist; Tore Saxne; Victoria Romanus; Lars Klareskog; Nils Feltelius
Journal:  Arthritis Rheum       Date:  2005-07

Review 7.  Cutaneous tuberculosis overview and current treatment regimens.

Authors:  Lindi van Zyl; Jeanetta du Plessis; Joe Viljoen
Journal:  Tuberculosis (Edinb)       Date:  2014-12-25       Impact factor: 3.131

Review 8.  Cutaneous tuberculosis: diagnosis and treatment.

Authors:  Joseph Barbagallo; Patricia Tager; Rosemary Ingleton; Ranella J Hirsch; Jeffrey M Weinberg
Journal:  Am J Clin Dermatol       Date:  2002       Impact factor: 7.403

9.  Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.

Authors:  Tan N Doan; Damon P Eisen; Morgan T Rose; Andrew Slack; Grace Stearnes; Emma S McBryde
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

10.  Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines.

Authors:  Tasnim Hasan; Eric Au; Sharon Chen; Allison Tong; Germaine Wong
Journal:  BMJ Open       Date:  2018-09-12       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.